Selumetinib: A Selective MEK1 Inhibitor for Solid Tumor Treatment

By
Justin.choi
-
0
121
The efficacy of selumetinib in various solid tumors such as colorectal cancer, lung cancer, neurofibroma, and melanoma is investigated.
[Clinical and Experimental Medicine]
Abstract